TD Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$75.3M Buy
194,783
+26,459
+16% +$9.81M 0.07% 228
2026
Q1
$49.3M Buy
168,324
+5,031
+3% +$1.65M 0.04% 319
2025
Q4
$57.2M Sell
163,293
-11,285
-6% -$3.81M 0.05% 293
2025
Q3
$56.4M Sell
174,578
-30,934
-15% -$9.62M 0.05% 297
2025
Q2
$79.9M Buy
205,512
+7,138
+4% +$2.87M 0.07% 225
2025
Q1
$86.3M Sell
198,374
-8,675
-4% -$3.48M 0.08% 211
2024
Q4
$76.4M Sell
207,049
-42,394
-17% -$17.7M 0.07% 237
2024
Q3
$131M Sell
249,443
-19,492
-7% -$10.4M 0.12% 169
2024
Q2
$146M Buy
268,935
+1,874
+0.7% +$991K 0.14% 153
2024
Q1
$138M Sell
267,061
-10,171
-4% -$5.06M 0.13% 160
2023
Q4
$131M Sell
277,232
-86,949
-24% -$40.2M 0.13% 149
2023
Q3
$159M Buy
364,181
+92,231
+34% +$41.8M 0.19% 99
2023
Q2
$121M Sell
271,950
-27,525
-9% -$12.7M 0.14% 130
2023
Q1
$138M Sell
299,475
-6,798
-2% -$3.24M 0.17% 118
2022
Q4
$157M Buy
306,273
+142,630
+87% +$72.4M 0.19% 106
2022
Q3
$74.8M Buy
163,643
+5,976
+4% +$2.86M 0.09% 173
2022
Q2
$76.1M Sell
157,667
-5,405
-3% -$2.67M 0.09% 179
2022
Q1
$80.1M Sell
163,072
-36
-0% -$16.5K 0.07% 203
2021
Q4
$75.6M Buy
163,108
+1,618
+1% +$681K 0.06% 233
2021
Q3
$60.2M Sell
161,490
-59
-0% -$22.4K 0.06% 242
2021
Q2
$62M Sell
161,549
-128,450
-44% -$49.1M 0.06% 242
2021
Q1
$104M Buy
289,999
+4,381
+2% +$1.41M 0.12% 140
2020
Q4
$91.7M Sell
285,618
-27,287
-9% -$8.37M 0.11% 156
2020
Q3
$84M Buy
312,905
+28,338
+10% +$7.62M 0.12% 155
2020
Q2
$74.8M Buy
284,567
+25,374
+10% +$6.77M 0.11% 159
2020
Q1
$58.8M Buy
259,193
+16,266
+7% +$4.43M 0.1% 162
2019
Q4
$73.4M Sell
242,927
-31,713
-12% -$8.73M 0.11% 165
2019
Q3
$65.9M Sell
274,640
-74,088
-21% -$20.3M 0.1% 174
2019
Q2
$98.4M Sell
348,728
-192,051
-36% -$52.5M 0.15% 125
2019
Q1
$155M Buy
540,779
+34,338
+7% +$9.93M 0.24% 81
2018
Q4
$133M Buy
506,441
+20,834
+4% +$5.73M 0.23% 83
2018
Q3
$133M Buy
485,607
+36,615
+8% +$9.51M 0.2% 91
2018
Q2
$107M Buy
448,992
+45,909
+11% +$10.6M 0.16% 115
2018
Q1
$88.6M Buy
403,083
+64,482
+19% +$15.1M 0.14% 140
2017
Q4
$76.2M Buy
338,601
+53,476
+19% +$11.4M 0.11% 152
2017
Q3
$54.1M Sell
285,125
-9,627
-3% -$1.83M 0.08% 192
2017
Q2
$55.5M Sell
294,752
-1,121
-0.4% -$201K 0.09% 185
2017
Q1
$48.9M Sell
295,873
-6,432
-2% -$1.02M 0.08% 203
2016
Q4
$43.5M Sell
302,305
-22,578
-7% -$3.02M 0.07% 217
2016
Q3
$40.7M Sell
324,883
-68,709
-17% -$8.87M 0.07% 226
2016
Q2
$51.7M Sell
393,592
-46,542
-11% -$6.37M 0.09% 186
2016
Q1
$61.2M Sell
440,134
-19,943
-4% -$2.66M 0.11% 148
2015
Q4
$64.2M Sell
460,077
-16,600
-3% -$2.29M 0.13% 143
2015
Q3
$66.7M Buy
476,677
+59,100
+14% +$8.88M 0.13% 132
2015
Q2
$68.5M Buy
417,577
+165,157
+65% +$26.4M 0.12% 143
2015
Q1
$39M Buy
252,420
+47,704
+23% +$6.79M 0.07% 220
2014
Q4
$25.7M Sell
204,716
-5,508
-3% -$681K 0.04% 292
2014
Q3
$25.1M Buy
210,224
+19,742
+10% +$2.26M 0.04% 290
2014
Q2
$20.5M Buy
190,482
+16,820
+10% +$1.73M 0.03% 327
2014
Q1
$17.3M Sell
173,662
-72,300
-29% -$6.54M 0.03% 354
2013
Q4
$22.7M Sell
245,962
-16,995
-6% -$1.51M 0.04% 277
2013
Q3
$22M Buy
262,957
+37,350
+17% +$3.2M 0.04% 274
2013
Q2
$18.5M Buy
+225,607
New +$16.9M 0.04% 292

Other funds holding ELV

TD Asset Management's ELV Position: Q2 2026 in Review

TD Asset Management increased its Elevance Health (ELV) stake by 16% in Q2 2026, buying an estimated $9.81M and bringing the position to 194,783 shares worth $75.3M. The position accounts for 0.07% of the portfolio, ranked #228.

TD Asset Management first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $159M in Q3 2023. 1,303 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • TD Asset Management held 194,783 shares of Elevance Health worth $75.3M as of Q2 2026.
  • TD Asset Management bought 26,459 Elevance Health shares in Q2 2026, an estimated $9.81M.
  • Elevance Health made up 0.07% of TD Asset Management's portfolio in Q2 2026, its #228 holding.
  • TD Asset Management first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
  • TD Asset Management's Elevance Health position peaked at $159M in Q3 2023.
  • 1,303 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.